16.7
Arzneistofffreisetzungssysteme mit modifizierter Wirkstofffreisetzung: ratenprogrammierte Systeme I
Ratenprogrammierte Arzneistofffreisetzungssysteme, oder DDS, sind so konzipiert, dass sie Wirkstoffe mit spezifischen, kontrollierten Freisetzungsrate…
Ratenprogrammierte DDS setzt Medikamente mit kontrollierten Raten frei, indem Methoden wie polymere Matrix, Reservoir, Osmotikpumpe und Mikrochipsysteme verwendet werden. Ratenprogrammierte Arzneimittelabgabesysteme umfassen verschiedene Typen.
In einem lösungsgesteuerten DDS hängt die Freisetzungsrate von der langsamen Auflösung des Medikaments oder der umgebenden Matrix ab.
Medikamente mit langsamer Auflösung lösen sich allmählich auf, während andere bei Kontakt mit Magen-Darm-Flüssigkeiten in langsamer lösende Formen übergehen.
Ein weiterer Ansatz integriert Medikamente in langsam auflösende Matrizen oder beschichtet sie mit langsam lösenden Materialien, um die Flüssigkeitspenetration zu kontrollieren.
In einem diffusionsgesteuerten DDS hängt die Freisetzungsrate von der Diffusion der gelösten Arzneimittelmoleküle durch ein geschwindigkeitskontrollierendes Element ab, das nicht abbaubar und entweder wasseraufschwellbar oder unlöslich ist.
Polymere wie Xanthangummi, HPMC und Ethylcellulose werden häufig in diesen Arzneimittelabgabesystemen verwendet.
Lösungs- und diffusionsgesteuertes DDS kombinieren beide Mechanismen und verwenden Materialien, die die Freisetzungsrate des Arzneimittels durch Auflösung und Diffusion regulieren.
View the full transcript and gain access to JoVE Core videos
Q1: What are the main types of rate-programmed drug delivery systems?
Rate-programmed drug delivery systems include dissolution-controlled, diffusion-controlled, and combined dissolution-diffusion-controlled approaches. Dissolution-controlled systems rely on slow drug or matrix dissolution. Diffusion-controlled systems use non-degradable barriers that regulate drug diffusion. Combined systems integrate both mechanisms to achieve precise, sustained release and maintain consistent therapeutic levels.
Q2: How does dissolution control drug release in modified release systems?
In dissolution-controlled systems, release rate depends on how slowly the drug or surrounding matrix dissolves. Drugs with inherently slow dissolution rates, like griseofulvin and digoxin, dissolve gradually in gastrointestinal fluids. Some drugs transform into slower-dissolving forms upon contact with GI fluids, extending release. Embedding drugs in slowly dissolving matrices or coating them with slow-dissolving materials further regulates fluid penetration and delays drug release.
Q3: What role do polymers play in diffusion-controlled drug delivery?
Polymers form rate-controlling barriers that regulate drug diffusion without dissolving or degrading. Water-swellable polymers like xanthan gum, HPMC, and alginates absorb fluid while maintaining structural integrity. Water-insoluble polymers such as ethyl cellulose and polymethacrylates create stable diffusion barriers. These materials ensure steady, predictable drug release by controlling how dissolved drug molecules pass through the barrier.
Q4: How do combined dissolution-diffusion systems improve drug delivery control?
Combined dissolution-diffusion-controlled systems integrate slow-dissolving coatings with diffusion barriers to enhance release precision. By utilizing materials that influence both dissolution and diffusion processes simultaneously, these hybrid designs achieve superior control over drug release rates. This dual-mechanism approach provides flexible solutions for medications requiring prolonged absorption, improving patient compliance and treatment efficiency.
Q5: What is the difference between water-swellable and water-insoluble polymers in drug delivery?
Water-swellable polymers like xanthan gum and HPMC absorb gastrointestinal fluids while remaining structurally intact, allowing controlled drug diffusion through the swollen matrix. Water-insoluble polymers such as ethyl cellulose and polymethacrylates do not absorb fluid but form impermeable barriers that regulate drug passage. Both types maintain non-degradable, stable structures throughout drug delivery, ensuring predictable release kinetics.
Q6: Why are rate-programmed systems beneficial for patient compliance?
Rate-programmed systems maintain consistent therapeutic drug levels by releasing medication at controlled rates, reducing dosing frequency and improving patient compliance. By providing prolonged absorption and sustained therapeutic effects, these systems enhance treatment efficiency and reduce the burden of frequent medication administration. This controlled approach ensures better therapeutic outcomes while minimizing side effects associated with fluctuating drug concentrations.
Q7: How do drugs like ferrous sulfate behave differently in dissolution-controlled systems?
Ferrous sulfate transforms into a slower-dissolving form when exposed to gastrointestinal fluids, extending its release profile in dissolution-controlled systems. This chemical transformation upon contact with GI fluids naturally slows drug dissolution, allowing gradual absorption. Such drugs demonstrate how dissolution-controlled systems can exploit inherent drug properties to achieve sustained release without requiring additional matrix or coating materials.